- Home
- Personal stories
Personal stories
Evolving and growing protein-based bioelectronics: Meet WiSTEM2D Scholars Award Winner Noémie-Manuelle Dorval Courchesne
Each year, Johnson & Johnson selects outstanding female researchers from across the globe who are driving breakthroughs in STEM2D. See how recent winners are using the critical funding and mentorship opportunities that come along with the WiSTEM2D Scholars Award.
Looking at malaria from a mathematical perspective: Meet WiSTEM2D Scholars Award Winner Dr. Miranda Teboh-Ewungkem
Each year, Johnson & Johnson selects outstanding female researchers from across the globe who are driving breakthroughs in STEM2D. See how recent winners are using the critical funding and mentorship opportunities that come along with the WiSTEM2D Scholars Award.
Restoring quality of life for patients with facial bone defects: Get to know WiSTEM2D Scholars Award Winner Dr. Ange Therese Akono
Each year, Johnson & Johnson selects outstanding female researchers from across the globe who are driving breakthroughs in STEM2D. See how recent winners are using the critical funding and mentorship opportunities that come along with the WiSTEM2D Scholars Award.
136 years of championing women’s health
Supporting the well-being of people around the world is a tenet that underscores all the work the company does. From must-have educational manuals to cutting-edge contraception, explore how Johnson & Johnson has been advocating for women’s health since the company’s inception more than a century ago.
Powering implantable medical devices: Meet Dr. Feifei Shi, WiSTEM2D Scholars Award Winner in the field of technology
Each year, Johnson & Johnson selects outstanding female researchers from across the globe who are driving breakthroughs in STEM2D. See how recent winners are using the critical funding and mentorship opportunities that come along with the WiSTEM2D Scholars Award.
How to set social impact targets in an uncertain world
For J&J Impact Ventures, an investment fund within the J&J Foundation, a social impact target can’t encompass all the dimensions of impact, but it does need to go beyond funds committed or disbursed and towards giving an indication of real-world change.
Meet 3 men who’ve been on the front lines of HIV treatments for decades
Johnson & Johnson’s Brian Woodfall, M.D., was working at a Vancouver clinic in the mid-1990s. That’s where he met Tiko Kerr, who became one of the first patients to take the company’s HIV medicines—and has thrived to this day. For National AIDS Awareness Month, watch as Kerr, Dr. Woodfall and fellow researcher Joss J. De Wet, M.D., reflect on how those treatments have saved lives and continue to evolve, in this moving video.
What you need to know about Johnson & Johnson’s 2022 second-quarter earnings
Check out this infographic breakdown of the company’s second-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
What it really feels like to have aphasia
Imagine if you were trying to speak and no one could understand you. That’s what it’s like to live with this language-impairing condition. For National Aphasia Awareness Month, learn how to spot the symptoms of the neurological disorder and what to do if you’re afflicted.
“Why I decided to undergo facial feminization surgery”
For International Transgender Day of Visibility, Lynn Discenza shares her transition journey and how gender-affirmation surgery helped her reclaim her confidence and be who she’s always wanted to be. Plus, learn how Johnson & Johnson MedTech is working to help ensure more people have access to the life-changing procedure.